Policy | May 29, 2021
Shilpa Medicare Jadcherla facility gets GMP certification from Russia
The GMP certificate is valid for three years until April 2024.
The GMP certificate is valid for three years until April 2024.
It posted net profit of Rs.60.96 crores for the 12 months period ended March 31, 2021
The company has registered total income of Rs. 3,847 crores for Q4 FY21, up by 3% on a y-o-y basis from Rs. 3,752 crores registered during corresponding period of the previous year
MEK inhibitor compound (LNP3794) developed as part of its oncology pipeline had previously shown pre-clinical activity as a single agent as well as in combination
Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
This marks Glenmark's first synthetic decapeptide injectable approval
First batch produced at Panacea Biotec’s facilities at Baddi will be shipped to the Gamaleya Center for quality control and full scale production of the vaccine is due to start this summer
NATCO and Arrow shall launch the product on agreed-upon launch dates in the future.
NATCO Pharmaceuticals, Hyderabad; Alembic Pharmaceuticals, Vadodara; Gufic Biosciences Ltd., Gujarat; Emcure Pharmaceuticals, Pune; and Lyka, Gujarat are new manufacturers
Subscribe To Our Newsletter & Stay Updated
